Emily Downward
Daniel Malito is an advocate on two of Health Union’s communities: RheumatoidArthritis.net and Blood-Cancer.com. I had the opportunity to interview …
Ronni Gordon, an advocate here on Blood-Cancer.com, was recently interviewed for the Health Union podcast Living With. Ronni was diagnosed …
Heart disease is the leading cause of death in Americans, but new research shows that cancer is likely to surpass …
On November 28, 2018, the U.S. Food and Drug Administration (FDA) approved two new products that affect the blood cancer …
The U.S. Food and Drug Administration (FDA) recently approved two new treatment options for certain people with acute myeloid leukemia …
I recently attended a fascinating discussion in precision medicine in cancer care. Precision medicine is the tailoring of treatment for …
The U.S. Food and Drug Administration (FDA) recently approved Empliciti® (elotuzumab) as part of a combination treatment to treat certain …
CD1, or cyclin D1, is a protein that is involved with cell development and growth. All cells grow and divide, …
On September 28, 2018, the U.S. Food and Drug Administration (FDA) approved the first next-generation sequencing-based test to detect very …
On September 24, 2018, the U.S. Food and Drug Administration (FDA) approved a new treatment for certain types of blood …
Mantle cell lymphoma is a rare form of non-Hodgkin lymphoma (NHL) that arises from B cell lymphocytes, a type of …
On September 13, 2018, the U.S. Food and Drug Administration (FDA) approved a new treatment option for adults with hairy …
Of those who responded to our 2018 Blood Cancer In America survey, 32% were impacted by lymphoma, a type of …
In our 2018 Blood Cancer In America survey, people living with blood cancer shared their perspective on how the condition …
In our 2018 Blood Cancer In America survey, over 2,500 people impacted by blood cancer shared their experiences about diagnosis, …
The U.S. Food and Drug Administration (FDA) has recently expanded the approval for Venclexta® (venetoclax). Venclexta is now approved to …
A diagnosis of cancer carries a psychosocial and physical impact for anyone, and for the youngest patients, there are added …
The U.S. Food and Drug Administration (FDA) has recently expanded the usage of Darzalex® (daratumumab): it is now approved to …
The U.S. Food and Drug Administration (FDA) recently expanded the approval of Kymriah™ (tisagenlecleucel) to include adults with diffuse large …
